Cure My Disease

Don't miss your cure!

 Log in / Sign up

Real-World study tracks Osimertinib's impact on lung cancer survival

NCT ID NCT05103605

Ongoing Knowledge-focused Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study observes how the drug osimertinib works in real-life settings for people with advanced lung cancer that has a specific genetic change (EGFR mutation). About 274 adults in France will be followed for up to 3 years to see how long they live, how their disease changes, and their quality of life. The goal is to understand the drug's effectiveness outside of controlled clinical trials.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NON-SMALL CELL LUNG CANCER

Contacts and locations

Locations

  • Research Site

    Abbeville, France

  • Research Site

    Aix-en-Provence, France

  • Research Site

    Angers, France

  • Research Site

    Antibes, France

  • Research Site

    Avignon, France

  • Research Site

    Bastia, France

  • Research Site

    Bayonne, France

  • Research Site

    Bordeaux, France

  • Research Site

    Bourg-en-Bresse, France

  • Research Site

    Brest, France

  • Research Site

    Cannes, France

  • Research Site

    Chambéry, France

  • Research Site

    Chauny, France

  • Research Site

    Cholet, France

  • Research Site

    Clermont-Ferrand, France

  • Research Site

    Colmar, France

  • Research Site

    Contamine-sur-Arve, France

  • Research Site

    Créteil, France

  • Research Site

    Elbeuf, France

  • Research Site

    Epagny METZ Tessy, France

  • Research Site

    Évreux, France

  • Research Site

    La Roche-sur-Yon, France

  • Research Site

    Libourne, France

  • Research Site

    Limoges, France

  • Research Site

    Lyon, France

  • Research Site

    Marseille, France

  • Research Site

    Meaux, France

  • Research Site

    Mulhouse, France

  • Research Site

    Orléans, France

  • Research Site

    Paris, France

  • Research Site

    Poitiers, France

  • Research Site

    Quimper, France

  • Research Site

    Reims, France

  • Research Site

    Rouen, France

  • Research Site

    Saint-Denis, France

  • Research Site

    Saint-Grégoire, France

  • Research Site

    Saint-Pierre, France

  • Research Site

    Saint-Priest-en-Jarez, France

  • Research Site

    Saint-Quentin, France

  • Research Site

    Toulon, France

  • Research Site

    Toulouse, France

  • Research Site

    Valenciennes, France

  • Research Site

    Vannes, France

  • Research Site

    Villefranche-sur-Saône, France

  • Research Site

    Villenave-dornon, France

  • Research Site

    Villeurbanne, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.